Use of computational software in drug research is growing, and some big tech companies are angling for a piece of this market. Cadence Design Systems is entering the life sciences sector through the $500 million acquisition of OpenEye Scientific, a company that provides computational drug design software to the pharmaceutical industry.
BrightInsight, a startup developing infrastructure to make it easier for companies to make their own health apps, raised $101 million in funding. General Catalyst led the series C round.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
VitalConnect's CEO Peter Van Haur believes his company's product not only does a great job in real time cardiac remote monitoring but also has something larger competitors lack: the ability to monitor other vital signs
The Bay Area hearing device-maker planned to raise $141.3 million in an upsized IPO. Its stock started trading on Nasdaq under the ticker “EAR.”
A partially redacted document filed in federal court last week in connection with the trial stated that Holmes planned to obtain an evaluation from a psychologist. The court allowed federal prosecutors to obtain an evaluation from their own experts as well.
Outset Medical, a San Jose-based company making portable dialysis machines, filed the initial paperwork for an IPO. The company has not yet set a price range for its stock, but said it plans to raise roughly $100 million.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Venclose has received $27 million in Series C funding to expand market share for it venous reflux therapy. This RF ablation device is designed to simplify treatment and reduce procedure times.
San Jose-based BrightInsight is a spin-off from contract manufacturer Flex and has raised funding for its internet-of-things platform for connected medical devices and drug delivery systems.
Two executives have launched a new Silicon Valley firm, MDisrupt, designed to assess the medical claims made by health tech startups to help investors to separate the wheat from chaff and guide startups seeking to commercialize products.
Various news outlets reported that attorneys for Holmes successfully convinced a federal judge to delay setting a trial date in order to get more time to review some 20 million pages of documents.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
At an industry conference hosted by the largest medtech lobby, CMS officials hint that they have arrived at a decision regarding Foundation Medicine's genetic test.
At a medtech industry conference, the FDA Commissioner forcefully called for legislation to regulate the lab-developed testing industry and said he is speaking to lawmakers on Capitol Hill.
Flex, a global electronics contract manufacturer, is reshaping itself to grow its $2 billion healthcare business and believes its take on the future will help traditional medtech companies fare better.
Valley Health Plan, a California-based organization with 160,000 members, has implemented AxisPoint Health's CarePoint condition management solution.
The company, which wants to disrupt the dialysis service model, envisions its dialysis device eventually being used in patient homes.